Drug Report History #110839

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.

Field Version v4-FR Version v4-FR
Language French French
Date Updated 2020-09-18 2020-09-18
Drug Identification Number 02242811 02242811
Brand name SCOPOLAMINE HYDROBROMIDE INJECTION SCOPOLAMINE HYDROBROMIDE INJECTION
Common or Proper name Scopolamine Hydrobromide Injection Scopolamine Hydrobromide Injection
Company Name OMEGA LABORATORIES LTD OMEGA LABORATORIES LTD
Ingredients SCOPOLAMINE HYDROBROMIDE SCOPOLAMINE HYDROBROMIDE
Strength(s) 0.6MG 0.6MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 1mL vial /fiole 10 x 1mL vial /fiole
ATC code N05CM N05CM
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-02 2020-04-02
Estimated end date Unknown Unknown
Actual end date 2020-09-16 2020-09-16
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments On Allocation (Covid-19) On Allocation (Covid-19)
Health Canada comments